TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA)
CUSIP: 881624209
Q2 2017 13F Holders as of 30 Jun 2017
- Type / Class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Shares outstanding
- 1,148,777,709
- Total 13F shares
- 588,457,468
- Share change
- +12,296,615
- Total reported value
- $19,529,211,322
- Put/Call ratio
- 159%
- Price per share
- $33.22
- Number of holders
- 644
- Value change
- +$426,728,940
- Number of buys
- 286
- Number of sells
- 319
Quarterly Holders Quick Answers
What is CUSIP 881624209?
CUSIP 881624209 identifies TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 881624209:
Top shareholders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
|
Company |
5.8%
|
67,064,633
|
$2,152,104,000 | — | 31 Mar 2017 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
5.2%
|
60,111,053
|
$1,928,992,000 | — | 31 Mar 2017 | |
| FMR LLC |
13F
|
Company |
3.2%
|
36,729,126
|
$1,178,638,000 | — | 31 Mar 2017 | |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC |
13F
|
Company |
2.6%
|
29,753,982
|
$954,805,000 | — | 31 Mar 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.4%
|
27,789,148
|
$891,752,000 | — | 31 Mar 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.7%
|
19,398,405
|
$622,496,000 | — | 31 Mar 2017 | |
| HIGHFIELDS CAPITAL MANAGEMENT LP |
13F
|
Company |
1.5%
|
17,718,350
|
$568,582,000 | — | 31 Mar 2017 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.5%
|
17,679,845
|
$567,345,000 | — | 31 Mar 2017 | |
| Northern Cross, LLC |
13F
|
Company |
1.4%
|
15,611,407
|
$500,970,000 | — | 31 Mar 2017 | |
| Invesco Ltd. |
13F
|
Company |
1.3%
|
14,801,119
|
$474,967,000 | — | 31 Mar 2017 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
1.1%
|
12,572,916
|
$403,465,000 | — | 31 Mar 2017 | |
| NORGES BANK |
13F
|
Company |
1%
|
11,436,970
|
$367,012,000 | — | 31 Mar 2017 | |
| PAULSON & CO. INC. |
13F
|
Company |
0.96%
|
10,997,300
|
$352,903,000 | — | 31 Mar 2017 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.75%
|
8,617,143
|
$276,524,000 | — | 31 Mar 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.74%
|
8,503,916
|
$272,891,000 | — | 31 Mar 2017 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
0.7%
|
8,079,885
|
$259,283,000 | — | 31 Mar 2017 | |
| Capital World Investors |
13F
|
Company |
0.68%
|
7,800,000
|
$250,302,000 | — | 31 Mar 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.68%
|
7,783,243
|
$249,765,000 | — | 31 Mar 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.54%
|
6,235,996
|
$200,112,000 | — | 31 Mar 2017 | |
| Camber Capital Management LP |
13F
|
Company |
0.45%
|
5,216,450
|
$167,396,000 | — | 31 Mar 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.42%
|
4,817,763
|
$154,602,000 | — | 31 Mar 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.42%
|
4,778,346
|
$153,337,000 | — | 31 Mar 2017 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.4%
|
4,567,429
|
$149,401,000 | — | 31 Mar 2017 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.4%
|
4,603,699
|
$147,733,000 | — | 31 Mar 2017 | |
| STATE STREET CORP |
13F
|
Company |
0.39%
|
4,530,768
|
$145,390,000 | — | 31 Mar 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.38%
|
4,344,377
|
$139,412,000 | — | 31 Mar 2017 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.34%
|
3,878,943
|
$124,495,000 | — | 31 Mar 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.33%
|
3,751,467
|
$120,385,000 | — | 31 Mar 2017 | |
| Migdal Insurance & Financial Holdings Ltd. |
13F
|
Company |
0.31%
|
3,554,058
|
$114,065,000 | — | 31 Mar 2017 | |
| Swiss National Bank |
13F
|
Company |
0.3%
|
3,440,151
|
$110,394,000 | — | 31 Mar 2017 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.26%
|
3,014,088
|
$96,723,000 | — | 31 Mar 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.25%
|
2,817,937
|
$90,428,000 | — | 31 Mar 2017 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.24%
|
2,709,072
|
$86,933,000 | — | 31 Mar 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.24%
|
2,701,713
|
$86,696,000 | — | 31 Mar 2017 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.23%
|
2,657,316
|
$85,273,000 | — | 31 Mar 2017 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.22%
|
2,567,398
|
$82,388,000 | — | 31 Mar 2017 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.22%
|
2,542,800
|
$81,598,000 | — | 31 Mar 2017 | |
| THOMPSON SIEGEL & WALMSLEY LLC |
13F
|
Company |
0.21%
|
2,372,597
|
$76,136,000 | — | 31 Mar 2017 | |
| Appaloosa LP |
13F
|
Company |
0.19%
|
2,175,000
|
$69,796,000 | — | 31 Mar 2017 | |
| EARNEST PARTNERS LLC |
13F
|
Company |
0.19%
|
2,145,292
|
$68,842,000 | — | 31 Mar 2017 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.19%
|
2,140,516
|
$68,689,000 | — | 31 Mar 2017 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.18%
|
2,103,727
|
$67,508,000 | — | 31 Mar 2017 | |
| Polaris Capital Management, LLC |
13F
|
Company |
0.18%
|
2,100,147
|
$67,394,000 | — | 31 Mar 2017 | |
| EATON VANCE MANAGEMENT |
13F
|
Company |
0.18%
|
2,036,029
|
$65,336,000 | — | 31 Mar 2017 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.18%
|
2,022,219
|
$64,893,000 | — | 31 Mar 2017 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.17%
|
1,952,150
|
$62,644,000 | — | 31 Mar 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.17%
|
1,909,320
|
$61,270,000 | — | 31 Mar 2017 | |
| Epoch Investment Partners, Inc. |
13F
|
Company |
0.16%
|
1,886,121
|
$60,525,000 | — | 31 Mar 2017 | |
| UBS Group AG |
13F
|
Company |
0.16%
|
1,881,434
|
$60,376,000 | — | 31 Mar 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
1,860,426
|
$59,618,000 | — | 31 Mar 2017 |
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) as of Q2 2017
As of 30 Jun 2017,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) was held by
644 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
588,457,468 shares.
The largest 10 holders included
Capital Research Global Investors, FRANKLIN RESOURCES INC, FMR LLC, BARROW HANLEY MEWHINNEY & STRAUSS LLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, HIGHFIELDS CAPITAL MANAGEMENT LP, Bank of New York Mellon Corp, Northern Cross, LLC, and Invesco Ltd..
This page lists
644
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
683
Q2 2017 holders
644
Holder diff
-39
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 Value $ | Q2 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.